Kintara Therapeutics Inc [NASDAQ: KTRA] jumped around 0.01 points on Thursday, while shares priced at $0.16 at the close of the session, up 4.71%.
Compared to the average trading volume of 14.67M shares, KTRA reached a trading volume of 3781376 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Kintara Therapeutics Inc [KTRA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for KTRA shares is $14.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on KTRA stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
How has KTRA stock performed recently?
Kintara Therapeutics Inc [KTRA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.02. With this latest performance, KTRA shares gained by 21.28% in over the last four-week period, additionally sinking by -63.81% over the last 6 months – not to mention a drop of -95.26% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KTRA stock in for the last two-week period is set at 58.40, with the RSI for the last a single of trading hit 59.19, and the three-weeks RSI is set at 55.62 for Kintara Therapeutics Inc [KTRA]. The present Moving Average for the last 50 days of trading for this stock 0.1179, while it was recorded at 0.1508 for the last single week of trading, and 1.4796 for the last 200 days.
Kintara Therapeutics Inc [KTRA]: Deeper insight into the fundamentals
Kintara Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.63 and a Current Ratio set at 0.63.
Insider trade positions for Kintara Therapeutics Inc [KTRA]
The top three institutional holders of KTRA stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in KTRA stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in KTRA stock with ownership which is approximately 5.8386%.
